Cargando…

Testosterone-Lowering Medication and Its Association With Recidivism Risk in Individuals Convicted of Sexual Offenses

For a particular subgroup of individuals with severe paraphilic disorders and a high risk of sexual recidivism, the combination of sex drive–reducing medications and psychotherapy is a promising treatment approach. The present quasi-experimental study aims at comparing differences in clinical charac...

Descripción completa

Detalles Bibliográficos
Autores principales: Sauter, Julia, Turner, Daniel, Briken, Peer, Rettenberger, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072038/
https://www.ncbi.nlm.nih.gov/pubmed/32167420
http://dx.doi.org/10.1177/1079063220910723
_version_ 1783683837630349312
author Sauter, Julia
Turner, Daniel
Briken, Peer
Rettenberger, Martin
author_facet Sauter, Julia
Turner, Daniel
Briken, Peer
Rettenberger, Martin
author_sort Sauter, Julia
collection PubMed
description For a particular subgroup of individuals with severe paraphilic disorders and a high risk of sexual recidivism, the combination of sex drive–reducing medications and psychotherapy is a promising treatment approach. The present quasi-experimental study aims at comparing differences in clinical characteristics and dynamic risk factors between persons receiving (+TLM, n = 38) versus not receiving (−TLM, n = 22) testosterone-lowering medications (TLMs). Individuals receiving TLM were more frequently diagnosed with paraphilic disorders. Neither the criminal history nor average risk scores differed between the two groups. In the +TLM, Stable-2007 scores showed a stronger decrease after TLM treatment was started. This accounted especially for the general and sexual self-regulation subscales. Individual variations in risk, however, were not predicted by TLM but were significantly related to treatment duration and Psychopathy Checklist–Revised (PCL-R) Factor I. Paraphilic patients with problems in self-regulatory abilities seem to profit most from pharmacological sex drive–reducing treatment. Furthermore, therapists seem to underestimate deviant sexual fantasies in medicated patients.
format Online
Article
Text
id pubmed-8072038
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-80720382021-05-13 Testosterone-Lowering Medication and Its Association With Recidivism Risk in Individuals Convicted of Sexual Offenses Sauter, Julia Turner, Daniel Briken, Peer Rettenberger, Martin Sex Abuse Articles For a particular subgroup of individuals with severe paraphilic disorders and a high risk of sexual recidivism, the combination of sex drive–reducing medications and psychotherapy is a promising treatment approach. The present quasi-experimental study aims at comparing differences in clinical characteristics and dynamic risk factors between persons receiving (+TLM, n = 38) versus not receiving (−TLM, n = 22) testosterone-lowering medications (TLMs). Individuals receiving TLM were more frequently diagnosed with paraphilic disorders. Neither the criminal history nor average risk scores differed between the two groups. In the +TLM, Stable-2007 scores showed a stronger decrease after TLM treatment was started. This accounted especially for the general and sexual self-regulation subscales. Individual variations in risk, however, were not predicted by TLM but were significantly related to treatment duration and Psychopathy Checklist–Revised (PCL-R) Factor I. Paraphilic patients with problems in self-regulatory abilities seem to profit most from pharmacological sex drive–reducing treatment. Furthermore, therapists seem to underestimate deviant sexual fantasies in medicated patients. SAGE Publications 2020-03-13 2021-06 /pmc/articles/PMC8072038/ /pubmed/32167420 http://dx.doi.org/10.1177/1079063220910723 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Articles
Sauter, Julia
Turner, Daniel
Briken, Peer
Rettenberger, Martin
Testosterone-Lowering Medication and Its Association With Recidivism Risk in Individuals Convicted of Sexual Offenses
title Testosterone-Lowering Medication and Its Association With Recidivism Risk in Individuals Convicted of Sexual Offenses
title_full Testosterone-Lowering Medication and Its Association With Recidivism Risk in Individuals Convicted of Sexual Offenses
title_fullStr Testosterone-Lowering Medication and Its Association With Recidivism Risk in Individuals Convicted of Sexual Offenses
title_full_unstemmed Testosterone-Lowering Medication and Its Association With Recidivism Risk in Individuals Convicted of Sexual Offenses
title_short Testosterone-Lowering Medication and Its Association With Recidivism Risk in Individuals Convicted of Sexual Offenses
title_sort testosterone-lowering medication and its association with recidivism risk in individuals convicted of sexual offenses
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072038/
https://www.ncbi.nlm.nih.gov/pubmed/32167420
http://dx.doi.org/10.1177/1079063220910723
work_keys_str_mv AT sauterjulia testosteroneloweringmedicationanditsassociationwithrecidivismriskinindividualsconvictedofsexualoffenses
AT turnerdaniel testosteroneloweringmedicationanditsassociationwithrecidivismriskinindividualsconvictedofsexualoffenses
AT brikenpeer testosteroneloweringmedicationanditsassociationwithrecidivismriskinindividualsconvictedofsexualoffenses
AT rettenbergermartin testosteroneloweringmedicationanditsassociationwithrecidivismriskinindividualsconvictedofsexualoffenses